Incidence, Long-Term Outcomes, and Healthcare Utilization of Patients With Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Disseminated Mycobacterium avium Complex From 1992–2015
Open Access
- 6 June 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 4 (3) , ofx120
Abstract
Despite the advent of combination antiretroviral therapy (cART), patients with human immunodeficiency virus (HIV) continue to develop late-stage complications including acquired immune deficiency syndrome (AIDS), disseminated Mycobacterium avium complex (DMAC), and death. We performed an observational retrospective cohort study of HIV-infected adults who developed DMAC in the Duke University Health System from 1992 to 2015 to determine the incidence, long-term outcomes, and healthcare utilization of this population at high risk for poor outcomes. Findings were stratified by the “pre-cART” era (before January 1, 1996) and “post-cART” thereafter. We identified 330 adult HIV-infected patients newly diagnosed with DMAC, the majority (75.2%) of whom were male and non-Hispanic black (69.1%), with median age of 37 years. Incidence of DMAC declined significantly from 65.3/1000 in 1992 to 2.0/1000 in 2015, and the proportion of females and non-Hispanic blacks was significantly higher in the post-cART era. The standardized mortality ratios for DMAC patients who received cART were 69, 58, 27, 5.9, and 6.8 at years 1–5, respectively, after DMAC diagnosis. For patients diagnosed with DMAC in 2000 or later (n = 135), 20% were newly diagnosed with HIV in the 3 months preceding presentation with DMAC. Those with established HIV had a median time from HIV diagnosis to DMAC diagnosis of 7 years and were more likely to be black, rehospitalized in the 6 months after DMAC diagnosis, and die in the long term. Disseminated Mycobacterium avium complex continues to be a lethal diagnosis in the cART era, disproportionately afflicts minority populations, and reflects both delayed entry into care and failure to consistently engage care.Keywords
Funding Information
- National Institutes of Health (5T32AI007392-25)
This publication has 41 references indexed in Scilit:
- Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general populationAIDS, 2013
- Improvement in the Health of HIV-Infected Persons in Care: Reducing DisparitiesClinical Infectious Diseases, 2012
- U.S. Trends in Antiretroviral Therapy Use, HIV RNA Plasma Viral Loads, and CD4 T-Lymphocyte Cell Counts Among HIV-Infected Persons, 2000 to 2008Annals of Internal Medicine, 2012
- The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV InfectionClinical Infectious Diseases, 2011
- AIDS-defining opportunistic illnesses in US patients, 1994–2007: a cohort studyAIDS, 2010
- Inpatient Health Services Utilization Among HIV-Infected Adult Patients in Care 2002–2007JAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994–2005AIDS, 2008
- Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapyAIDS, 2007
- DisseminatedMycobacterium aviumComplex Disease among Patients Infected with Human Immunodeficiency Virus, 1985–2000Clinical Infectious Diseases, 2001
- Incidence of Mycobacterium avium-intracellulare Complex Bacteremia in Human Immunodeficiency Virus-Positive PatientsThe Journal of Infectious Diseases, 1992